With 0.98 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.0 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $17.0 whereas the lowest price it dropped to was $15.67. The 52-week range on LMRI shows that it touched its highest point at $19.45 and its lowest point at $15.24 during that stretch. It currently has a 1-year price target of $22.71.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of LMRI was down-trending over the past week, with a drop of -7.88%, but this was down by -13.50% over a month.
Float and Shares Shorts:
At present, 625.71 million LMRI shares are outstanding with a float of 94.22 million shares on hand for trading. In addition to Ms. Caitlin Zulla as the firm’s CEO & Director, Mr. J. Anthony Martin serves as its Chief Financial Officer.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With LMRI analysts setting a high price target of 23.0 and a low target of 22.0, the average target price over the next 12 months is 22.71429. Based on these targets, LMRI could surge 43.57% to reach the target high and rise by 37.33% to reach the target low. Reaching the average price target will result in a growth of 41.79% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Based on analyst estimates, the high estimate for the next quarter is $0.19 and the low estimate is $0.14. The average estimate for the next quarter is thus $0.16.
